2025-05-02 11:03:01
Latest Post
Godrej Agrovet Limited consolidated Q4FY25 net profit drops QoQ to Rs. 70.78 crores
L G Balakrishnan & Bros Ltd posts Rs. 84.03 crores consolidated profit in Q4FY25
Swastika Investmart Ltd Q4 FY2025 consolidated profit slumps to Rs. 27.17 lakhs
Vertex Securities Ltd consolidated Q4 FY25 loss at Rs. 53.99 lakhs
The Federal Bank Limited consolidated Q4FY25 PAT jumps to Rs. 1108.31 crores
Stock Report
Wockhardt's Q1FY 22 Revenue grew by 36% over previous quarter & EBITDA grew many fold at Rs.108 crore
Posted On : 2021-07-22 13:39:03( TIMEZONE : IST )
Wockhardt Limited, the Pharmaceutical and Biotechnology major, reported its 1st Quarter Results for Financial Year 2021-22, today.
The Company recorded substantial growth in Revenue (up by 36% over previous quarter & 32% over previous corresponding quarter) and in EBITDA at Rs.108 crore compared to a loss of Rs.(49) crore in the corresponding quarter of the previous year. Profit after Tax (PAT) for the Quarter was Rs. (13) crore against Rs. (93) crore in the previous quarter.
Net Debt-Equity ratio as on 30th June, 2021 stood at 0.55 (31st March, 2021 stood at 0.54).
Business Review:
Quarter ended 30th June, 2021:
- UK Business grew by 86% over previous corresponding quarter and stood at Rs.407 crore in Q1FY22 (PY Rs.218 crore). UK Business contributed about 47% of Global Revenue. Major growth has come from the COVID-19 Vaccine business.
- India Business: The Continuing India Business stood at Rs.152 in Q1FY22 (PY Rs.62 crore) registering growth of 144%. Total India Business (Continued and Discontinued Operations) stood at Rs.152 crore in Q1FY22 as compared to Rs.116 crore in Q1FY21 - a growth of 31%. India Business contributed 18% of the Global Revenue.
- Emerging Markets Business of the Company stood at Rs.124 crore in Q1FY22 (PY Rs.139 crore). Emerging Markets Business contributed about 14% of the Global Revenue.
- Irish Business stood at Rs.36 crore in Q1FY22 (PY Rs.33 crore).
- US Business stood at Rs.102 crore in Q1FY22 as compared to Rs.114 crore in Q1FY21. US Business contributed 12% of the Global Revenue.
Research and Development expenditure during the quarter was at Rs.34 crore (4% to sales) and including capital expenditure was at 8.5% to sales.
Capital expenditure during the quarter was Rs.40 crore.
Shares of WOCKHARDT LTD. was last trading in BSE at Rs. 557.2 as compared to the previous close of Rs. 580.2. The total number of shares traded during the day was 97614 in over 3605 trades.
The stock hit an intraday high of Rs. 588 and intraday low of 548.15. The net turnover during the day was Rs. 54806788.
